8Q26
HsNMT1 in complex with both MyrCoA and GNCFSKPR inhibitor peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM14 |
Synchrotron site | ESRF |
Beamline | BM14 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-11-04 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.96112 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 79.220, 177.870, 57.930 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 47.470 - 1.900 |
R-factor | 0.1636 |
Rwork | 0.161 |
R-free | 0.20600 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.006 |
RMSD bond angle | 0.840 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | PHENIX (1.17_3644) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.540 | 1.950 |
High resolution limit [Å] | 1.900 | 1.900 |
Rpim | 0.037 | |
Number of reflections | 64915 | 4487 |
<I/σ(I)> | 20.3 | |
Completeness [%] | 99.6 | |
Redundancy | 4.7 | |
CC(1/2) | 0.999 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M MgCl2, 0.2 M NaCl, 0.1 M sodium citrate pH 5.6, and 18-24% (w/v) PEG 6K or 8K |